TY  -  JOUR 
TI  - Development Of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation In Patients With Breast Cancer History: Case Report
PB  - American Thoracic Society
PY  - 2016
issn 1073-449X
AB  - Mutation of exons 19 and 21 encoding for Epidermal Growth Factor Receptor (EGFR) tyrosine Kinase domain, is found in 15-20% of lung adenocarcinomas (NSCLC) and in 0.8-1.4% of breast carcinomas (BC) with negative hormonal receptors. Radiotherapy is considered an indiscriminate activation factor of EGFR. Objetive: To report 2 cases of BC treated with chemo radiotherapy that later developed NSCLC with EGFR mutation
KW  - Ciencias socio biomédicas
KW  - Medical sciences
KW  - Adenocarcinoma
KW  - Pulmones - Enfermedades
KW  - Tumor
KW  - Cáncer de mama
UR  - http://hdl.handle.net/10906/81355
ER  -